Identification of Two New Mutations in the Glucokinase Gene That Result in Maturity-Onset Diabetes of the Young
Author(s) -
Seth D. Marks,
Robert Couch
Publication year - 2010
Publication title -
diabetes care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.636
H-Index - 363
eISSN - 1935-5548
pISSN - 0149-5992
DOI - 10.2337/dc10-0685
Subject(s) - glucokinase , medicine , maturity onset diabetes of the young , diabetes mellitus , gene , identification (biology) , maturity (psychological) , genetics , mutation , age of onset , endocrinology , type 2 diabetes , biology , disease , psychology , developmental psychology , botany
Glucokinase catalyzes glucose to glucose-6-phosphate conversion in the pancreatic β-cell and is a key regulator of insulin secretion (1). The glucokinase gene ( GCK ) on chromosome 7p15.3–15.1 has 12 exons. GCK heterozygous inactivating mutations result in mild fasting hyperglycemia termed maturity-onset diabetes of the young type 2 (MODY2) or MODY-GCK (MIM # 125851) (2). The mutations result in diminished insulin secretion (3) and possibly decreased hepatic glucose uptake and glycogen synthesis (4). Several hundred inactivating mutations throughout exons 2 to 10 have been described (5). We report two previously undescribed mutations.Both patients were assessed at the Pediatric Diabetes Education Centre, Stollery Children's Hospital, Edmonton, Canada. Glucose and A1C …
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom